{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Exicure", "item": "https://www.patentleaderboard.com/2021/company/exicure"}, {"@type": "ListItem", "position": 4, "name": "Subbarao Nallagatla", "item": "https://www.patentleaderboard.com/2021/inventor/fl:su_ln:nallagatla-1"}]}

Home › 2021 › Exicure › Subbarao Nallagatla

SN

Subbarao Nallagatla — 2 Patents in 2021

EXExicure: 1 patents #1 of 6Top 20%

San Diego, CA: #998 of 4,495 inventorsTop 25%

California: #13,721 of 66,859 inventorsTop 25%

Overall (2021): #108,651 of 548,734Top 20%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11123294	Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications	Aleksandar Filip Radovic-Moreno, Richard Kang, Christopher C. Mader, Sergei Gryaznov	2021-09-21
10894963	Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use	Aleksandar Filip Radovic-Moreno, Christopher C. Mader, Warefta Hasan, Aaron Love, Sergei Gryaznov	2021-01-19	$4,085,000

Subbarao Nallagatla — 2 Patents in 2021

Issued Patents 2021

Patent Widget